Importance
Fostamatinib, a spleen tyrosine kinase inhibitor, has been reported to improve outcomes of COVID-19.Objective
To evaluate the efficacy and safety of fostamatinib in adults hospitalized with COVID-19 and hypoxemia.Design, setting, and participants
This multicenter, ...